scholarly journals Causes and consequences of child growth failure in low- and middle-income countries

Author(s):  
Andrew Mertens ◽  
Jade Benjamin-Chung ◽  
John M Colford ◽  
Jeremy Coyle ◽  
Mark J van der Laan ◽  
...  

AbstractChild growth failure is associated with a higher risk of illness and mortality,1 which contributed to the United Nations Sustainable Development Goal 2.2 to end malnutrition by 2030. Current prenatal and postnatal interventions, such as nutritional supplementation, have been insufficient to eliminate growth failure in low resource settings —motivating a search for key age windows and population subgroups in which to focus future preventive efforts. Quantifying the effect of early growth failure on severe outcomes is important to assess burden and longer-term impacts on the child. Here we show through an analysis of 35 longitudinal cohorts (108,336 children) that maternal and child characteristics at birth accounted for the largest attributable differences in growth. Yet, postnatal growth failure was larger than differences at birth, and characteristics of the child’s household environment were additional determinants of growth failure after age 6 months. Children who experienced early ponderal or linear growth failure were at much higher risk of persistent growth failure and were 2.0 to 4.8 times more likely to die by age 24 months. High attributable risk from prenatal causes, and severe consequences for children who experienced early growth failure, support a focus on pre-conception and pregnancy as key opportunities for new preventive interventions. Our results suggest that broad improvements in wellbeing will be necessary to eliminate growth failure in low resource settings, but that screening based on weight could help identify children at highest risk of death before age 24 months.

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Davide Piaggio ◽  
Rossana Castaldo ◽  
Marco Cinelli ◽  
Sara Cinelli ◽  
Alessia Maccaro ◽  
...  

Abstract Background To date (April 2021), medical device (MD) design approaches have failed to consider the contexts where MDs can be operationalised. Although most of the global population lives and is treated in Low- and Middle-Income Countries (LMCIs), over 80% of the MD market share is in high-resource settings, which set de facto standards that cannot be taken for granted in lower resource settings. Using a MD designed for high-resource settings in LMICs may hinder its safe and efficient operationalisation. In the literature, many criteria for frameworks to support resilient MD design were presented. However, since the available criteria (as of 2021) are far from being consensual and comprehensive, the aim of this study is to raise awareness about such challenges and to scope experts’ consensus regarding the essentiality of MD design criteria. Results This paper presents a novel application of Delphi study and Multiple Criteria Decision Analysis (MCDA) to develop a framework comprising 26 essential criteria, which were evaluated and chosen by international experts coming from different parts of the world. This framework was validated by analysing some MDs presented in the WHO Compendium of innovative health technologies for low-resource settings. Conclusions This novel holistic framework takes into account some domains that are usually underestimated by MDs designers. For this reason, it can be used by experts designing MDs resilient to low-resource settings and it can also assist policymakers and non-governmental organisations in shaping the future of global healthcare.


PEDIATRICS ◽  
2015 ◽  
Vol 136 (1) ◽  
pp. e84-e92 ◽  
Author(s):  
J. D. Horbar ◽  
R. A. Ehrenkranz ◽  
G. J. Badger ◽  
E. M. Edwards ◽  
K. A. Morrow ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Noelle E. Younge ◽  
Christopher B. Newgard ◽  
C. Michael Cotten ◽  
Ronald N. Goldberg ◽  
Michael J. Muehlbauer ◽  
...  

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Soon Min Lee ◽  
Namhyo Kim ◽  
Ran Namgung ◽  
Minsoo Park ◽  
Kookin Park ◽  
...  

2020 ◽  
Vol 40 (5) ◽  
pp. 704-714 ◽  
Author(s):  
Tanis R. Fenton ◽  
Barbara Cormack ◽  
Dena Goldberg ◽  
Roseann Nasser ◽  
Belal Alshaikh ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Alison Chu ◽  
Yasmeen Dhindsa ◽  
Myung Shin Sim ◽  
Marie Altendahl ◽  
Irena Tsui

Abstract Low birthweight and decreased postnatal weight gain are known predictors of worse retinopathy of prematurity (ROP) but the role of prenatal growth patterns in ROP remains inconclusive. To distinguish small for gestational age (SGA) from intrauterine growth restriction (IUGR) as independent predictors of ROP, we performed a retrospective cohort study of patients who received ROP screening examinations at a level IV neonatal intensive care unit over a 7-year period. Data on IUGR and SGA status, worst stage of and need for treatment for ROP, and postnatal growth was obtained. 343 infants were included for analysis (mean gestational age = 28.6 weeks and birth weight = 1138.2 g). IUGR infants were more likely to have a worse stage of ROP and treatment-requiring ROP (both p < 0.0001) compared to non-IUGR infants. IUGR infants were more likely to be older at worst stage of ROP (p < 0.0001) and to develop postnatal growth failure (p = 0.01) than non-IUGR infants. Independent of postnatal growth failure status, IUGR infants had a 4–5 × increased risk of needing ROP treatment (p < 0.001) compared to non-IUGR infants. SGA versus appropriate for gestational age infants did not demonstrate differences in retinopathy outcomes, age at worst ROP stage, or postnatal growth failure. These findings emphasize the importance of prenatal growth on ROP development.


Sign in / Sign up

Export Citation Format

Share Document